125 related articles for article (PubMed ID: 10513893)
1. The structural basis for the susceptibility of gangliosides to enzymatic degradation.
Sonnino S; Brocca P; Acquotti D; Bernardi A; Raimondi L; Kiso M; Ishida H; Li SC; Li YT
Biosci Rep; 1999 Jun; 19(3):163-8. PubMed ID: 10513893
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural characterization of N-acetyl- and N-glycolylneuraminic-acid-containing GalNAc-GD1a isomers, IV4GalNAcIV3Neu5AcII3Neu5GcGgOse4Cer and IV4GalNAcIV3Neu5GcII3Neu5AcGgOse4Cer, from bovine brain.
Casellato R; Brocca P; Li SC; Li YT; Sonnino S
Eur J Biochem; 1995 Dec; 234(3):786-93. PubMed ID: 8575436
[TBL] [Abstract][Full Text] [Related]
3. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.
Li YT; Li SC; Kiso M; Ishida H; Mauri L; Raimondi L; Bernardi A; Sonnino S
Biochim Biophys Acta; 2008 Mar; 1780(3):353-61. PubMed ID: 17967427
[TBL] [Abstract][Full Text] [Related]
4. Three dimensional structure of GD1b and GD1b-monolactone gangliosides in dimethylsulphoxide: a nuclear Overhauser effect investigation supported by molecular dynamics calculations.
Acquotti D; Fronza G; Ragg E; Sonnino S
Chem Phys Lipids; 1991 Sep; 59(2):107-25. PubMed ID: 1742806
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation.
Li YT; Li SC; Hasegawa A; Ishida H; Kiso M; Bernardi A; Brocca P; Raimondi L; Sonnino S
J Biol Chem; 1999 Apr; 274(15):10014-8. PubMed ID: 10187778
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside/calmodulin kinase II signal inducing cdc42-mediated neuronal actin reorganization.
Chen N; Furuya S; Doi H; Hashimoto Y; Kudo Y; Higashi H
Neuroscience; 2003; 120(1):163-76. PubMed ID: 12849750
[TBL] [Abstract][Full Text] [Related]
7. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
8. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
9. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
Trinchera M; Ghidoni R
J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
[TBL] [Abstract][Full Text] [Related]
10. Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.
Song Y; Kitajima K; Inoue S; Khoo KH; Morris HR; Dell A; Inoue Y
Glycobiology; 1995 Mar; 5(2):207-18. PubMed ID: 7540078
[TBL] [Abstract][Full Text] [Related]
11. Geometrical and conformational properties of ganglioside GalNAc-GD1a, IV4GalNAcIV3Neu5AcII3Neu5AcGgOse4Cer.
Acquotti D; Cantù L; Ragg E; Sonnino S
Eur J Biochem; 1994 Oct; 225(1):271-88. PubMed ID: 7925447
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics-derived conformation and intramolecular interaction analysis of the N-acetyl-9-O-acetylneuraminic acid-containing ganglioside GD1a and NMR-based analysis of its binding to a human polyclonal immunoglobulin G fraction with selectivity for O-acetylated sialic acids.
Siebert HC; von der Lieth CW; Dong X; Reuter G; Schauer R; Gabius HJ; Vliegenthart JF
Glycobiology; 1996 Sep; 6(6):561-72. PubMed ID: 8922951
[TBL] [Abstract][Full Text] [Related]
13. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
14. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa.
Dohi T; Ohta S; Hanai N; Yamaguchi K; Oshima M
J Biol Chem; 1990 May; 265(14):7880-5. PubMed ID: 2139874
[TBL] [Abstract][Full Text] [Related]
15. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
[TBL] [Abstract][Full Text] [Related]
16. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus).
DeGasperi R; Li SC; Li YT
J Biol Chem; 1988 Jan; 263(3):1325-8. PubMed ID: 2961751
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the N1 and N2 sialidase subtypes of human influenza A virus for natural and synthetic gangliosides.
Sato K; Hanagata G; Kiso M; Hasegawa A; Suzuki Y
Glycobiology; 1998 Jun; 8(6):527-32. PubMed ID: 9592119
[TBL] [Abstract][Full Text] [Related]
18. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
19. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
Merritt WD; Richardson CL; Keenan TW; Morré DJ
J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy.
Ilyas AA; Li SC; Chou DK; Li YT; Jungalwala FB; Dalakas MC; Quarles RH
J Biol Chem; 1988 Mar; 263(9):4369-73. PubMed ID: 2450092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
